Valuation Eli Lilly and Company

Stocks

Market Closed - NYSE Other stock markets 21:01:00 08/06/2026 BST			After hours 01:00:00
1,149.15 ^USD	+1.57%		1,150.00	+0.07%

10:20am	Eli Lilly Enters Licensing Deal With AlzeCure Pharma for Alzheimer's Drug Candidate	MT
08:41am	Roche sticks to German investment after Eli Lilly cuts	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	250,419	347,613	524,224	695,134	962,248	1,024,745	-	-
Change	-	38.81%	50.81%	32.6%	38.43%	6.49%	-	-
Enterprise Value (EV) ¹	263,395	361,640	546,522	725,355	997,483	1,042,198	1,021,715	992,684
Change	-	37.3%	51.12%	32.72%	37.52%	4.48%	-1.97%	-2.84%
P/E ratio	45.1x	53x	101x	65.9x	46.8x	33.6x	27.2x	22.9x
PBR	29.4x	32.7x	48.9x	49x	36.3x	20.1x	13.2x	9.13x
PEG	-	4.2x	-6.3x	1x	0.5x	0.7x	1.2x	1.2x
Capitalization / Revenue	8.84x	12.2x	15.4x	15.4x	14.8x	12x	10.4x	9.27x
EV / Revenue	9.3x	12.7x	16x	16.1x	15.3x	12.2x	10.4x	8.98x
EV / EBITDA	26.3x	38.2x	63.7x	45.1x	34.1x	25.2x	20.1x	16.9x
EV / EBIT	31.1x	45.5x	77.4x	50.7x	36.6x	25.7x	21.3x	18x
EV / FCF	44.3x	69.1x	690x	193x	111x	50.1x	35.6x	28.4x
FCF Yield	2.26%	1.45%	0.15%	0.52%	0.9%	1.99%	2.81%	3.52%
Dividend per Share ²	3.4	3.92	4.52	5.2	6	6.822	7.544	8.359
Rate of return	1.23%	1.07%	0.78%	0.67%	0.56%	0.59%	0.66%	0.73%
EPS ²	6.12	6.9	5.8	11.71	22.95	34.18	42.23	50.14
Distribution rate	55.6%	56.8%	77.9%	44.4%	26.1%	20%	17.9%	16.7%
Net sales ¹	28,318	28,541	34,124	45,043	65,179	85,279	98,159	110,598
EBITDA ¹	10,005	9,472	8,584	16,079	29,271	41,420	50,941	58,895
EBIT ¹	8,457	7,950	7,057	14,313	27,274	40,619	48,017	55,209
Net income ¹	5,582	6,245	5,240	10,590	20,640	30,987	37,835	44,963
Net Debt ¹	12,976	14,027	22,298	30,221	35,235	17,453	-3,030	-32,061
Reference price ²	276.22	365.84	582.92	772.00	1,074.68	1,149.15	1,149.15	1,149.15
Nbr of stocks (in thousands)	906,592	950,178	899,307	900,432	895,381	891,741	-	-
Announcement Date	03/02/22	02/02/23	06/02/24	06/02/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.62x	12.22x	25.16x	0.59%	1,025B
JOHNSON & JOHNSON	24.81x	5.72x	15.56x	2.3%	559B
ABBVIE INC.	27.31x	6.66x	13.61x	3.08%	394B
ROCHE HOLDING AG	17.31x	4.28x	10.51x	3.11%	324B
MERCK & CO., INC.	53.32x	4.96x	20.16x	2.8%	295B
ASTRAZENECA PLC	23.32x	4.83x	13.75x	1.81%	286B
NOVARTIS AG	20.51x	5.3x	12.89x	3.08%	270B
NOVO NORDISK A/S	12.03x	4.53x	9.26x	4.17%	186B
AMGEN INC.	22.48x	6.03x	10.53x	2.92%	187B
GILEAD SCIENCES, INC.	-45.84x	5.54x	31.24x	2.53%	159B
Average	18.89x	6.01x	16.27x	2.64%	368.53B
Weighted average by Cap.	24.91x	7.29x	17.71x	2.17%